NeuroPace (Nasdaq:NPCE) today announced that it intends to sell common stock in an underwritten public offering worth $65 ...

MOUNTAIN VIEW, Calif. - NeuroPace, Inc. (NASDAQ: NPCE), a medical device company specializing in epilepsy treatment with a current market capitalization of $357 million, announced today its plans to ...

Additionally given a 30-day option to buy up to an extra 975,000 shares at the same price are underwriters. About $49.5 ...

NeuroPace expects to use approximately $49.5 million of the net proceeds from the offering to repurchase 5,270,845 shares held by NeuroPace’s significant stockholder, KCK Ltd., at $9.40 per share, ...